CGH
BMRN icon

Crossmark Global Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Crossmark Global Holdings’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
51,220
+130
+0.3% +$7.12K 0.04% 364
2026
Q1 		$2.89M Sell
51,090
-18,380
-26% -$1.07M 0.04% 352
2025
Q4 		$4.13M Sell
69,470
-4,688
-6% -$255K 0.06% 285
2025
Q3 		$4.02M Buy
74,158
+21,000
+40% +$1.2M 0.06% 284
2025
Q2 		$2.92M Buy
53,158
+40,229
+311% +$2.37M 0.05% 335
2025
Q1 		$914K Buy
12,929
+23
+0.2% +$1.55K 0.02% 639
2024
Q4 		$848K Sell
12,906
-416
-3% -$27.9K 0.02% 627
2024
Q3 		$937K Buy
13,322
+2,277
+21% +$190K 0.02% 631
2024
Q2 		$909K Buy
+11,045
New +$920K 0.02% 614
2023
Q2 		– Sell
-2,128
Closed -$207K – 1302
2023
Q1 		$207K Buy
2,128
+105
+5% +$10.9K ﹤0.01% 1214
2022
Q4 		$209K Buy
+2,023
New +$190K 0.01% 1183
2018
Q4 		– Sell
-5,218
Closed -$506K – 1408
2018
Q3 		$506K Sell
5,218
-80
-2% -$7.99K 0.01% 940
2018
Q2 		$499K Sell
5,298
-550
-9% -$48.2K 0.01% 948
2018
Q1 		$474K Sell
5,848
-1,848
-24% -$159K 0.01% 948
2017
Q4 		$686K Buy
7,696
+228
+3% +$19.8K 0.02% 798
2017
Q3 		$695K Buy
+7,468
New +$660K 0.02% 768
2016
Q3 		$695K Buy
+7,468
New +$703K 0.02% 768

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Crossmark Global Holdings's BMRN Position: Q2 2026 in Review

Crossmark Global Holdings increased its BioMarin Pharmaceuticals (BMRN) stake by 0.25% in Q2 2026, buying an estimated $7.12K and bringing the position to 51,220 shares worth $2.93M. The position accounts for 0.04% of the portfolio, ranked #364.

Crossmark Global Holdings first reported a position in BMRN in Q3 2016 and has held it in 17 quarters since. The position peaked at $4.13M in Q4 2025. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Crossmark Global Holdings held 51,220 shares of BioMarin Pharmaceuticals worth $2.93M as of Q2 2026.
  • Crossmark Global Holdings bought 130 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $7.12K.
  • BioMarin Pharmaceuticals made up 0.04% of Crossmark Global Holdings's portfolio in Q2 2026, its #364 holding.
  • Crossmark Global Holdings first reported a position in BioMarin Pharmaceuticals in Q3 2016 and has held it in 17 quarters since.
  • Crossmark Global Holdings's BioMarin Pharmaceuticals position peaked at $4.13M in Q4 2025.
  • 564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.